Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FAH05
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,787
Award facts
- Contract value 100% obligated
- $9,787.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,787.17 on November 3, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulations. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of November 4, 2025. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company was competitively awarded this contract and maintains an extensive portfolio of federal pharmaceutical deliveries through the DLA Medical Supply Chain. As the prime contractor on this delivery order, AmerisourceBergen supplies specialty medications and medical commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally.
Quick answers
Who was awarded contract SPE2DB26FAH05?
SPE2DB26FAH05 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FAH05 worth?
The government has obligated $9,787 on SPE2DB26FAH05.
Is contract SPE2DB26FAH05 an order under another contract?
Yes. SPE2DB26FAH05 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB26FAH05 competed?
The extent of competition for SPE2DB26FAH05 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award